Skip to main content
. 2019 Sep 30;9(12):2025–2040. doi: 10.1002/2211-5463.12650

Figure 3.

Figure 3

Prospecting membrane disruptive property of UA–norfloxacin combination against clinical isolate MRSA‐2071. (A) Membrane permeabilization using PI through spectrofluorimetry. Data represent mean ± SEM of three independent experiments (**P ≤ 0.01, ***P ≤ 0.001, Dunnett's test). (B) Dissipation of membrane potential by increase in the fluorescence of DiSC 3‐(5) with the treatment of UA and norfloxacin alone as well as in combination at different concentrations (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, Dunnett’s test). Forma; Formaldehyde; Gluta; Glutaraldehyde.